The Ohio State University Research Foundation;UNIV OHIO STATE RES FOUND;The Government of The United States of America, as represented by The Secretary, Department of Health and Human Services
发明人:
Croce, Carlo M.,Ambs, Stefan,CROCE CARLO M,CROCE, CARLO M.,AMBS STEFAN,AMBS, STEFAN
申请号：
ES14170625
公开号：
ES2600165T3
申请日:
2009.02.27
申请国别(地区):
ES
年份:
2017
代理人:
摘要：
Use of an isolated miR-32 gene product comprising a miR antagonist to increase the response of prostate cancer cells to apoptotic stimuli, wherein the miR antagonist comprises an oligonucleotide sequence complementary to miR-32, or a precursor of the same.Uso de un producto del gen miR-32 aislado que comprende un antagonista de miR para aumentar la respuesta de células de cáncer de próstata a estímulos apoptóticos, en donde el antagonista de miR comprende una secuencia de oligonucleótido complementaria a miR-32, o un precursor del mismo.
